Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis

被引:16
作者
Appleton, Sarah E. [1 ]
Fadel, Zahir [1 ]
Williams, Jason S. [1 ]
Bezuhly, Michael [1 ]
机构
[1] Dalhousie Univ, Div Plast & Reconstruct Surg, 5850-5980 Univ Ave,POB 9700, Halifax, NS B3K 6R8, Canada
关键词
AMERICAN-JOINT-COMMITTEE; TUMOR-INFILTRATING LYMPHOCYTES; CUTANEOUS MALIGNANT-MELANOMA; DISEASE-FREE SURVIVAL; EARLY-STAGE MELANOMA; MITOTIC RATE; CLINICAL STAGE; THERAPEUTIC UTILITY; COST-EFFECTIVENESS; BRESLOW THICKNESS;
D O I
10.1097/PRS.0000000000004395
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The 2010 American Joint Committee on Cancer guidelines recommended consideration of sentinel lymph node biopsy for thin melanoma (Breslow thickness <1.0 mm) with aggressive pathologic features such as ulceration and/or high mitotic rate. The therapeutic benefit of biopsy-based treatment remains controversial. The authors conducted a meta-analysis to estimate the risk and outcomes of sentinel lymph node positivity in thin melanoma, and examined established and potential novel predictors of positivity. Methods: Three databases were searched by two independent reviewers for sentinel lymph node positivity in patients with thin melanoma. Study heterogeneity, publication bias, and quality were assessed. Data collected included age, sex, Breslow thickness, mitotic rate, ulceration, regression, Clark level, tumor-infiltrating lymphocytes, and vertical growth phase. Positivity was estimated using a random effects model. Association of positivity and clinicopathologic features was investigated using meta-regression. Results: Ninety-three studies were identified representing 35,276 patients with thin melanoma who underwent sentinel lymph node biopsy. Of these patients, 952 had a positive sentinel lymph node biopsy, for an event rate of 5.1 percent (95 percent CI, 4.1 to 6.3 percent). Significant associations were identified between positivity and Breslow thickness greater than 0.75 mm but less than 1.0 mm, mitotic rate, ulceration, and Clark level greater than IV. Seven studies reported on vertical growth phase, which was strongly associated with positivity (OR, 4.3; 95 percent CI, 2.5 to 7.7). Conclusions: To date, this is the largest meta-analysis to examine predictors of sentinel lymph node biopsy positivity in patients with thin melanoma. Vertical growth phase had a strong association with biopsy positivity, providing support for its inclusion in standardized pathologic reporting.
引用
收藏
页码:1529 / 1540
页数:12
相关论文
共 115 条
[1]   Cost-effectiveness of sentinel lymph node biopsy in thin melanomas [J].
Agnese, DM ;
Abdessalam, SF ;
Burak, WE ;
Magro, CM ;
Pozderac, RV ;
Walker, MJ .
SURGERY, 2003, 134 (04) :542-547
[2]  
Amin M.B., 2017, AM JOINT COMMITTEE C, V8th
[3]   Sentinel Lymph Node Biopsy for Melanoma in Pregnant Women [J].
Andtbacka, Robert H. I. ;
Donaldson, Matthew R. ;
Bowles, Tawnya L. ;
Bowen, Glen M. ;
Grossmann, Kenneth ;
Khong, Hung ;
Grossman, Douglas ;
Anker, Christopher ;
Florell, Scott R. ;
Bowen, Anneli ;
Duffy, Keith L. ;
Leachman, Sancy A. ;
Noyes, R. Dirk .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (02) :689-696
[4]  
Avilés-Izquierdo JA, 2009, ACTAS DERMO-SIFILOGR, V100, P486
[5]   Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients [J].
Balch, Charles M. ;
Thompson, John F. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Ding, Shouluan ;
McMasters, Kelly M. ;
Coit, Daniel G. ;
Eggermont, Alexander M. M. ;
Gimotty, Phyllis A. ;
Johnson, Timothy M. ;
Kirkwood, John M. ;
Leong, Stanley P. ;
Ross, Merrick I. ;
Byrd, David R. ;
Cochran, Alistair J. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Atkins, Michael B. ;
Flaherty, Keith T. ;
Sondak, Vernon K. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (04) :1075-1081
[6]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[7]  
Balch CM, 2003, ANN SURG, V238, P549
[8]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[9]   Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy [J].
Bartlett, Edmund K. ;
Gimotty, Phyllis A. ;
Sinnamon, Andrew J. ;
Wachtel, Heather ;
Roses, Robert E. ;
Schuchter, Lynn ;
Xu, Xiaowei ;
Elder, David E. ;
Ming, Michael ;
Elenitsas, Rosalie ;
Guerry, DuPont ;
Kelz, Rachel R. ;
Czerniecki, Brian J. ;
Fraker, Douglas L. ;
Karakousis, Giorgos C. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) :643-649
[10]   Incidence of sentinel node metastasis in patients with thin primary melanoma (≤1 mm) with vertical growth phase [J].
Bedrosian, I ;
Faries, MB ;
Guerry, D ;
Elenitsas, R ;
Schuchter, L ;
Mick, R ;
Spitz, FR ;
Bucky, LP ;
Alavi, A ;
Elder, DE ;
Fraker, DL ;
Czerniecki, BJ .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (04) :262-267